Femoroacetabular Impingement Clinical Trial
Official title:
Prevalence of Hip Pathomorphology in Collegiate Athletes and Age-Matched Controls: Radiographic and Physical Exam Findings
The primary objective of this study is to investigate factors hypothesized to influence the
prevalence of hip pathomorphology (femoroacetabular impingement, dysplasia) in young adults.
To complete this objective, we will quantify the prevalence of radiographic measures
indicative of hip pathomorphology in collegiate athletes and age-matched controls. This data
will allow us to test our main hypothesis, that the prevalence of hip pathomorphology is
higher in collegiate athletes than age-matched controls. To further elucidate the factors
which may increase the prevalence of hip pathomorphology, we will correlate the radiographic
measures to sport involvement history, hip function and demographics, as collected by means
of a questionnaire.
The secondary objective of this study is to determine if physical exams (range of motion,
impingement test) could be used to screen for radiographic measures of hip pathomorphology
in athletes and age-matched controls. To complete this objective, we will correlate range
physical exam results to the radiographic measures and determine each exam's sensitivity and
specificity to detect abnormal morphology.
Overview of Hip Pathomorphology. Osteoarthritis (OA) of the hip is the loss of articular
cartilage in the load bearing areas of the joint. OA affects one in six adults, with hip OA
affecting 9 million US citizens. Abnormal bony morphology of the femur and/or acetabulum
(herein called pathomorphology) is believed to initiate damage to the articular cartilage
and acetabular labrum and may predispose the hip to early OA. This study focuses on two
types of hip pathomorphology: femoroacetabular impingement (FAI) and acetabular dysplasia.
FAI is characterized by reduced clearance between the femoral head and acetabulum due to
femoral head/neck asphericity (cam FAI), acetabular overcoverage (pincer FAI), or a
combination of the two (mixed FAI). Dysplasia is characterized by a shallow or maloriented
acetabulum.
Elevated Risk of Hip Pathomorphology in Athletes. Hip pathomorphology is a common cause of
hip pain in athletes, and can limit or end sports participation. Collegiate and professional
athletes are considered at high risk for symptomatic FAI and dysplasia due to demands placed
on their hips during repetitive sport-specific motions. Sports which require
supra-physiologic hip motion may cause underlying bony abnormalities to become symptomatic
by initiating and/or aggravating chondrolabral damage. For example, hockey requires
repetitive hip flexion with internal rotation that is hypothesized to lead to increased
incidence and pain related to FAI.
Athletes are also considered at high risk for the development of symptomatic FAI because
they are hypothesized to have a higher prevalence of underlying bony abnormalities.
Radiographic findings consistent with hip pathomorphology are present not only in
symptomatic patients but also in asymptomatic individuals. In general population, previous
estimates of prevalence are 15-30% for FAI and 6-7% for dysplasia. It is hypothesized that
the prevalence of FAI in some athletes may be much higher, but the prevalence of dysplasia
is equivalent. High physical demand during the critical stages of hip development or beyond
may initiate remodeling, leading to abnormalities consistent with FAI. This remodeling is
not hypothesized to occur with dysplasia, but has not been investigated.
Diagnosis and Treatment of Hip Pathomorphology. Arthroscopic and open surgical treatment of
symptomatic FAI and dysplasia seeks to reduce pain, improve function and prevent/delay
osteoarthritis by restoring normal joint morphology. If surgery is performed before
radiographic evidence of osteoarthritis exists, most professional athletes can return to
their pre-surgery level of play. For example, 28 hockey players who underwent arthroscopic
treatment of FAI return to sports at a mean of 3.8 months. Interestingly, those who had
already developed arthritis or experienced a delay in treatment from the onset of hip pain
had a delayed return to sport. Thus, early diagnosis and prompt treatment may be important
to optimize clinical outcomes and facilitate the return to sport for athletic patients.
While the timeliness of a proper diagnosis continues to improve, misdiagnosis can occur by
clinicians not familiar with hip pathomorphology. For example, prior to being diagnosed with
FAI, many patients consult multiple health-care providers and even undergo unnecessary
surgical procedures. Even professional athletes are not treated immediately, with the
average time from onset of symptoms to treatment reported to be 29.6 months.
Motivation. While no study has supported prophylactic treatment of abnormal bony morphology
in asymptomatic hips, symptomatic hips could benefit from early treatment to prevent further
chondrolabral damage. The overall goal of this study is to improve the diagnosis and
timeliness of treatment of hip pathomorphology by 1) identifying "at-risk" populations and
2) determining if physical exams could be used to screen members of "at-risk" populations
for underlying abnormalities.
;
Time Perspective: Cross-Sectional
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01623843 -
Femoroacetabular Impingement RandomiSed Controlled Trial
|
N/A | |
Completed |
NCT03669471 -
Muscular and Functional Performance in FAIS Patients
|
||
Not yet recruiting |
NCT05031390 -
the Horsens Aarhus FemoroAcetabular Impingement Syndrome Training Pilot Study
|
N/A | |
Active, not recruiting |
NCT05025956 -
Senolytic Agent Improve the Benefit of Platelet-Rich Plasma and Losartan
|
Phase 1/Phase 2 | |
Withdrawn |
NCT02674113 -
Regional Anesthesia in Hip Arthroscopy
|
N/A | |
Withdrawn |
NCT02260726 -
Evaluation of Ultrasound for Detecting Hip Impingement
|
N/A | |
Recruiting |
NCT05391204 -
Reproducibility of Strength Testing and Functional Testing of the Hip for the Return to Sport of Patients Activated by a Femoroacetabular Impingement: Comparison Between a Group of Patients and a Group of Healthy Controls
|
N/A | |
Active, not recruiting |
NCT03891563 -
Prospective Evaluation of Sport Activity and the Development of Femoroacetabular Impingement in the Adolescent Hip
|
||
Active, not recruiting |
NCT04069507 -
Healthy Hip Study: Conservative Management for Pre-arthritic Hip Disorders
|
||
Terminated |
NCT03278353 -
Fulfillment of Expectations for Patients With FAI Syndrome
|
N/A | |
Terminated |
NCT03995290 -
3D Modeling to Improve Hip Arthroscopy Outcomes
|
||
Completed |
NCT06082271 -
Comparative, Randomized Study on the Anti-inflammatory and Regenerative Efficacy of a New Medical Device (DM) Based on Hydrolyzed Collagen Peptides in Patients With Femoro-acetabular Impingement Undergoing Hip Arthroscopy
|
N/A | |
Recruiting |
NCT01621360 -
Hip Arthroscopy Versus Conservative Management of Femoroacetabular Impingement
|
N/A | |
Completed |
NCT04980209 -
The Feasibility and Application of Intraoperative Ultrasound to Evaluate Femoral Head Shaping
|
||
Enrolling by invitation |
NCT04988659 -
Analysis of Gene Expression in Femoroacetabular Impingement (FAI)
|
||
Active, not recruiting |
NCT03494660 -
SCP Hip Outcomes Study
|
||
Active, not recruiting |
NCT04822571 -
Investigating the Reliability of Highly Dynamic 3D Motion Analysis Protocol in Adolescence and Adult Males
|
N/A | |
Withdrawn |
NCT02706756 -
Conservative Intervention of Femoroacetabular Impingement Syndrome
|
N/A | |
Completed |
NCT01993615 -
A Physical Therapy Program Versus Surgery for Femoroacetabular Impingement: Randomized Clinical Trial
|
N/A | |
Completed |
NCT01814124 -
Conservative Management of Femoroacetabular Impingement
|
N/A |